Category — Healthcare

India and China to Drive Global Vascular Access Market

According to London-based data and analytics company GlobalData, the centralvascular access devices market will grow from  $1.9 billion in 2015 to just over $2.3 billion by 2022.
Amen Sanghera, the analyst covering medical devices, said, “China and India will be responsible for a substantial proportion of the vascular access devices market growth over the forecast period, with CAGRs of 4.4% and 2.2% respectively. The European market, however, will see slow growth, with all five European countries registering CAGRs of less than 1 percent. The U.S. will continue to dominate, with its share slipping slightly from 40.7% in 2015 to 39.0% by 2022.”
Catheters
Biospectrum reports that vascular devices most commonly come in the form of thin and flexible catheters that are designed to intravenously deliver medication, nutrition, and fluids, and withdraw blood samples for further testing from large veins.

September 22, 2016   No Comments

India Streamlines Regulations for Clinical Research

With the aim of creating a conducive environment that fosters research and new drug development in India, the government has amended some critical clauses and framed new guidelines that are aligned to global regulations.
In an interview with BioSpectrum Asia Magazine, Suneela Thatte, president, Indian Society for Clinical Research said that India now has a very robust regulatory environment which is focused on quality, and where patient safety and confidentiality is not compromised.
“The compensation guidelines for clinical research are now more balanced and rational, and formulae have been introduced by the regulators for calculating the financial compensation based on a no-fault principle. This not only provides ease of implementation and consistency but also helps the sponsor of the trial to understand the maximum possible liability and plan appropriately while protecting the patient well being,” she said.
Clinical Trials

Restrictions on the number of clinical trials an investigator could do at a given point in time, and the minimum number of beds a clinical trial site needed to have, have been removed.Thatte added, “We hope the new regulatory environment will encourage more innovative and path-breaking R&D in our local biopharma companies as also in many of our well established teaching and academic institutions.

September 22, 2016   No Comments

India’s Genei Labs Acquires Merck’s GeNei

Bangalore, India-based Genei Laboratories led by Dr. S. Chandrashekaran acquired the manufacturing facilities of GeNei from Merck Life Sciences Private Limited in an asset purchase deal.
GeNei manufactures high-quality lab reagents in India since its founding in 1989. Its products range from molecular biology, genomics and proteomics reagents, to kits for use in teaching as well as contract research services, reports BioSpectrum.
Genei Labs
” While we bring to you the vast range of products and equipment associated with GeNei, we will also be working with new partners to introduce novel products and technologies. We aim to bring in innovative platform technologies for the development and manufacture of new reagents, peptides, biopharmaceuticals and diagnostic reagents. Our vision is to build a global Indian life sciences company offering cutting- edge products and technologies, ” said Dr. Chandrashekaran.

September 20, 2016   No Comments

Largest Number of Businesses in India are Retailers

With over  16 million  retail shops in the country — about one for every 15 families — this sector of work surpasses others in its numbers.

Manufacturing is second to retail with over 10 million units. However, the number of employees in this sector is greater than those in the retail trade. Most retail stores are tiny by Western standards and employ less than ten people.

Phoenix Mall in Mumbai

Phoenix Mall in Mumbai

Transport companies, warehousing, hotels and eateries, and healthcare-related enterprises are other major occupations, while educational enterprises have emerged as major employers.

These facts emerge from the 6th Economic Census conducted by the Government of India in 2013, detailed results of which were released earlier this year, reports the Times of India.

September 13, 2016   No Comments

Zimmer Biomet To Train 1,000 Indian Surgeons

Warsaw, Indiana-based medical device company Zimmer Biomet announced a multi-year collaboration with the Indo-U.K. Institutes of Health that will increase the capacity of India’s healthcare infrastructure. The Institute will help improve the delivery of healthcare across India by training more than 1,000 orthopedic surgeons annually on the latest orthopedic procedures and the safe and effective use of Zimmer Biomet medical technologies.

Zimmer Biomet

The first phase of the collaboration involves the establishment of the Zimmer Biomet Institute of Indiaa 30,000 square foot medical training and education facility on the campus of King’s College Hospital in Amaravati, in the eastern state of Andhra Pradesh.  Zimmer Biomet plans on investing $5 million in this facility over three years, starting in 2017. The King’s College Hospital in Amaravati is scheduled to break ground later this year, and is expected to create jobs for 2,500 nurses and 500 physicians.

Beckersspine  reports that the Indo UK Institutes of Health, along with the United Kingdom’s National Health Service, is also planning on establishing 11 “medicities” across India, which will include hospitals, medical schools and training centers. The initiative is backed by the U.K. and Indian prime ministers and governmental institutions, including U.K. Trade and Investment and Healthcare UK.

 

 

August 7, 2016   No Comments